Free Trial
NYSEAMERICAN:PTN

Palatin Technologies (PTN) Stock Price, News & Analysis

Palatin Technologies logo
$0.96 +0.05 (+5.01%)
(As of 10:38 AM ET)

About Palatin Technologies Stock (NYSEAMERICAN:PTN)

Key Stats

Today's Range
$0.92
$0.97
50-Day Range
N/A
52-Week Range
$0.68
$5.65
Volume
32,323 shs
Average Volume
347,226 shs
Market Capitalization
$18.77 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$17.00
Consensus Rating
Buy

Company Overview

Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that is in Phase 2 clinical trial for the treatment of inflammatory bowel diseases. In addition, the company engages in the development of PL9643, a peptide melanocortin agonist active at multiple MCrs, including MC1r and MC5r for anti-inflammatory ocular indications, such as dry eye disease, which is in Phase 3 clinical trial; and melanocortin peptides for diabetic retinopathy. Further, it is developing PL8177, an oral peptide formulation for treatment of ulcerative colitis, which entered Phase 2 clinical trials. The company was founded in 1986 and is based in Cranbury, New Jersey.

Palatin Technologies Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
33rd Percentile Overall Score

PTN MarketRank™: 

Palatin Technologies scored higher than 33% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Palatin Technologies has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Palatin Technologies has only been the subject of 1 research reports in the past 90 days.

  • Read more about Palatin Technologies' stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Palatin Technologies is -0.46, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Palatin Technologies is -0.46, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Percentage of Shares Shorted

    6.23% of the float of Palatin Technologies has been sold short.
  • Short Interest Ratio / Days to Cover

    Palatin Technologies has a short interest ratio ("days to cover") of 4.2.
  • Change versus previous month

    Short interest in Palatin Technologies has recently decreased by 7.87%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Palatin Technologies does not currently pay a dividend.

  • Dividend Growth

    Palatin Technologies does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    6.23% of the float of Palatin Technologies has been sold short.
  • Short Interest Ratio / Days to Cover

    Palatin Technologies has a short interest ratio ("days to cover") of 4.2.
  • Change versus previous month

    Short interest in Palatin Technologies has recently decreased by 7.87%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Palatin Technologies has a news sentiment score of 0.42. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 7 news articles for Palatin Technologies this week, compared to 2 articles on an average week.
  • Search Interest

    Only 5 people have searched for PTN on MarketBeat in the last 30 days. This is a decrease of -44% compared to the previous 30 days.
  • MarketBeat Follows

    Only 9 people have added Palatin Technologies to their MarketBeat watchlist in the last 30 days. This is a decrease of -47% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Palatin Technologies insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 7.10% of the stock of Palatin Technologies is held by insiders.

  • Percentage Held by Institutions

    Only 11.50% of the stock of Palatin Technologies is held by institutions.

  • Read more about Palatin Technologies' insider trading history.
Receive PTN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Palatin Technologies and its competitors with MarketBeat's FREE daily newsletter.

PTN Stock News Headlines

Palatin Technologies Shifts Focus to Obesity Treatments
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners
Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…
Palatin Technologies Inc. Loss At -$7.82 Mln In Q1
See More Headlines

PTN Stock Analysis - Frequently Asked Questions

Palatin Technologies' stock was trading at $4.00 at the beginning of 2024. Since then, PTN shares have decreased by 77.3% and is now trading at $0.91.
View the best growth stocks for 2024 here
.

Palatin Technologies, Inc. (NYSEAMERICAN:PTN) posted its quarterly earnings data on Tuesday, October, 1st. The biopharmaceutical company reported ($0.51) earnings per share for the quarter.

Palatin Technologies shares reverse split on Wednesday, August 31st 2022. The 1-25 reverse split was announced on Wednesday, August 31st 2022. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, August 31st 2022. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

Top institutional investors of Palatin Technologies include Virtu Financial LLC (0.29%) and XTX Topco Ltd (0.15%). Insiders that own company stock include Stephen T Wills, Alan W Dunton and Robert K Deveer Jr.
View institutional ownership trends
.

Shares of PTN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Palatin Technologies investors own include Invesco QQQ (QQQ), SPDR Dow Jones Industrial Average ETF Trust (DIA), SPDR S&P 500 ETF Trust (SPY), 22nd Century Group (XXII), NightHawk Biosciences (NHWK), NVIDIA (NVDA) and Meta Platforms (META).

Company Calendar

Last Earnings
10/01/2024
Today
11/21/2024
Fiscal Year End
6/30/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSEAMERICAN:PTN
Employees
30
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$17.00
High Stock Price Target
$17.00
Low Stock Price Target
$17.00
Potential Upside/Downside
+1,768.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-29,740,000.00
Pretax Margin
-1,590.66%

Debt

Sales & Book Value

Annual Sales
$4.49 million
Book Value
($0.01) per share

Miscellaneous

Free Float
18,160,000
Market Cap
$17.79 million
Optionable
Not Optionable
Beta
0.93
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

This page (NYSEAMERICAN:PTN) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners